Pulmonary arterial hypertension: genes and variants
Explore variant evidence for Pulmonary arterial hypertension across 6 analyzed proteins (BMPR2, ACVRL1, EIF2AK4, EDNRB, BMPR1A and 1 more). Linked ClinVar records include 32 pathogenic or likely pathogenic variants, 28 variants of uncertain significance and 5 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Pulmonary arterial hypertension
BMPR2: Bone morphogenetic protein receptor type-2
It initiates BMP signaling in vascular cells and helps maintain normal pulmonary-artery structure and endothelial function. Heterozygous loss-of-function variants are the most common known genetic cause of heritable pulmonary arterial hypertension.
29 ClinVar pathogenic / likely pathogenic and 21 uncertain variants in BMPR2 have source records linked to Pulmonary arterial hypertension. Association strength is not clinical gene validity.
ACVRL1: Activin receptor type-1-like
It mediates BMP9 and BMP10 signaling in vascular endothelial cells and helps maintain normal vessel maturation and quiescence. Heterozygous loss-of-function variants cause hereditary hemorrhagic telangiectasia type 2, with telangiectasias and arteriovenous malformations.
3 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in ACVRL1 have source records linked to Pulmonary arterial hypertension. Association strength is not clinical gene validity.
EIF2AK4: eIF-2-alpha kinase GCN2
It senses amino-acid deprivation and other stresses and reduces global translation through phosphorylation of eIF2alpha. Biallelic loss-of-function variants are a major cause of pulmonary capillary hemangiomatosis and pulmonary veno-occlusive disease.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in EIF2AK4 have source records linked to Pulmonary arterial hypertension. Association strength is not clinical gene validity.
EDNRB: Endothelin receptor type B
A G-protein-coupled receptor for endothelins that helps guide development of enteric neurons and melanocytes. Variants can cause Waardenburg-Shah syndrome, which can include Hirschsprung disease.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in EDNRB have source records linked to Pulmonary arterial hypertension. Association strength is not clinical gene validity.
BMPR1A: Bone morphogenetic protein receptor type-1A
It transduces BMP signals that regulate epithelial growth, differentiation, and tissue patterning through SMAD proteins and other pathways. Germline loss-of-function variants cause juvenile polyposis syndrome and can substantially increase gastrointestinal cancer risk.
0 ClinVar pathogenic / likely pathogenic and 5 uncertain variants in BMPR1A have source records linked to Pulmonary arterial hypertension. Association strength is not clinical gene validity.
ABCC8: ATP-binding cassette sub-family C member 8
It senses cellular nucleotide levels as the regulatory component of pancreatic beta-cell ATP-sensitive potassium channels and thereby couples glucose metabolism to insulin secretion. Loss-of-function variants cause congenital hyperinsulinism, whereas activating variants can cause neonatal diabetes.
0 ClinVar pathogenic / likely pathogenic and 6 uncertain variants in ABCC8 have source records linked to Pulmonary arterial hypertension. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): PHF6.
Where Pulmonary arterial hypertension variants cluster
- BMPR2 Protein kinase (positions 203–504): 20 of 29 ClinVar pathogenic / likely pathogenic variants, 2.4× more than its size predicts (a length-based count, not a validated hotspot).
- BMPR2 Extracellular (positions 27–150): 9 of 29 ClinVar pathogenic / likely pathogenic variants, 2.6× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Pulmonary arterial hypertension
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| BMPR2 E386A | 386 | Protein kinase | Pathogenic / likely pathogenic (★★★) |
| BMPR2 E386G | 386 | Protein kinase | Pathogenic / likely pathogenic (★★★) |
| BMPR2 E386V | 386 | Protein kinase | Pathogenic / likely pathogenic (★★★) |
| BMPR2 E386K | 386 | Protein kinase | Pathogenic / likely pathogenic (★★★) |
| BMPR2 E386Q | 386 | Protein kinase | Pathogenic / likely pathogenic (★★★) |
| BMPR2 C118W | 118 | Extracellular | Pathogenic / likely pathogenic (★★★) |
| BMPR2 R491Q | 491 | Protein kinase | Pathogenic / likely pathogenic (★★★) |
| BMPR2 A384V | 384 | Protein kinase | Pathogenic / likely pathogenic (★★★) |
| BMPR2 A391T | 391 | Protein kinase | Pathogenic / likely pathogenic (★★★) |
| BMPR2 G410R | 410 | Protein kinase | Pathogenic / likely pathogenic (★★★) |
| BMPR2 C420R | 420 | Protein kinase | Pathogenic / likely pathogenic (★★★) |
| BMPR2 C420Y | 420 | Protein kinase | Pathogenic / likely pathogenic (★★★) |
| BMPR2 C34R | 34 | Extracellular | Pathogenic / likely pathogenic (★★★) |
| BMPR2 C84Y | 84 | Extracellular | Pathogenic / likely pathogenic (★★★) |
| BMPR2 S301P | 301 | Protein kinase | Pathogenic / likely pathogenic (★★★) |
| BMPR2 R303H | 303 | Protein kinase | Pathogenic / likely pathogenic (★★★) |
| BMPR2 V339D | 339 | Protein kinase | Pathogenic / likely pathogenic (★★★) |
| BMPR2 L340P | 340 | Protein kinase | Pathogenic / likely pathogenic (★★★) |
| BMPR2 C347Y | 347 | Protein kinase | Pathogenic / likely pathogenic (★★★) |
| BMPR2 M406R | 406 | Protein kinase | Pathogenic / likely pathogenic (★★★) |
| ACVRL1 R484Q | 484 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| ACVRL1 R484G | 484 | Protein kinase | Pathogenic / likely pathogenic |
| BMPR2 C94R | 94 | Extracellular | Pathogenic / likely pathogenic |
| BMPR2 C94G | 94 | Extracellular | Pathogenic / likely pathogenic |
| BMPR2 C116R | 116 | Extracellular | Pathogenic / likely pathogenic |
| BMPR2 C117G | 117 | Extracellular | Pathogenic / likely pathogenic |
| BMPR2 D485G | 485 | Protein kinase | Pathogenic / likely pathogenic |
| ACVRL1 V216G | 216 | Protein kinase | Pathogenic / likely pathogenic |
| BMPR2 G68D | 68 | Extracellular | Pathogenic / likely pathogenic |
| BMPR2 C123R | 123 | Extracellular | Pathogenic / likely pathogenic |
| BMPR2 H306P | 306 | Protein kinase | Pathogenic / likely pathogenic |
| BMPR2 H331R | 331 | Protein kinase | Pathogenic / likely pathogenic |
Which prediction tools work for Pulmonary arterial hypertension
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- MutPred: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 99 out of 100
- AlphaMissense: 98 out of 100
- CATVariant: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 92 out of 100
Same protein, different disease
- Primary pulmonary hypertension also has ClinVar records linked to BMPR2 variants; they fall partly in the same places as the Pulmonary arterial hypertension variants (49 pathogenic / likely pathogenic).
- Hereditary hemorrhagic telangiectasia also has ClinVar records linked to ACVRL1 variants; they fall mostly in different places as the Pulmonary arterial hypertension variants (180 pathogenic / likely pathogenic).
- Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia also has ClinVar records linked to ACVRL1 variants; they fall mostly in different places as the Pulmonary arterial hypertension variants (6 pathogenic / likely pathogenic).
Diseases related to Pulmonary arterial hypertension
- Primary pulmonary hypertension, also linked to ACVRL1 and BMPR2
- Monogenic diabetes, also linked to ABCC8
- Hemophilia A, also linked to ACVRL1
- Hereditary hemorrhagic telangiectasia, also linked to ACVRL1
- Maturity-onset diabetes of the young, also linked to ABCC8
- Familial hyperinsulinemic hypoglycemia, also linked to ABCC8
- Type 2 diabetes mellitus, also linked to ABCC8
- Familial hyperinsulinism, also linked to ABCC8
- Waardenburg syndrome, also linked to EDNRB
- Atrial septal defect, also linked to ABCC8
- Diabetes mellitus, also linked to ABCC8
- Diabetes mellitus, permanent, also linked to ABCC8
Frequently asked questions
Which genes have records linked to Pulmonary arterial hypertension?
This view contains 6 analyzed proteins: BMPR2, ACVRL1, EIF2AK4, EDNRB, BMPR1A and 1 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 32 pathogenic or likely pathogenic variants, 28 variants of uncertain significance and 5 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 101 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center